Geriatric Medicine Doctors in Melbourne, FL Accepting Medicare

5 Geriatric Medicine doctors found. Showing 1 - 5

John H Potomski Jr., DO CMA Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 E New Haven Ave, Melbourne, FL 32901 Phone: 321-724-4545    Fax: 321-728-4168

Nirav K. Thakkar, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2200 W Eau Gallie Blvd Ste 200, Melbourne, FL 32935 Phone: 321-253-2900    Fax: 321-435-0100

Dr. Sarunas S. Skirk, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 N Wickham Rd, Suite 110, Melbourne, FL 32935 Phone: 321-757-7541    Fax: 321-757-7343

Arun Koshy, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Suite 2f, Melbourne, FL 32901 Phone: 321-725-4500    Fax: 321-768-5070

Dr. Alan Katz, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4100 W New Haven Ave Ste A, Melbourne, FL 32904 Phone: 321-340-7165    Fax: 321-340-5362

News Archive

New solutions needed to improve care and reduce cost of high-need, high-cost patients

By many estimates, only 5% of U.S. patients are high-need, high-cost, yet they account for about 50% of health care spending.

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.

Regular usage of CGM devices help manage diabetes

The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.

Catasys to provide assistance to Humana members experiencing substance abuse challenges

Catasys, Inc., a provider of proprietary big-data based analytics and predictive modeling driven health management services for health plans, announced today that it has signed a national agreement with Humana Behavioral Health to combine its substance abuse care management with Humana clinical programs to address the needs of members experiencing substance abuse challenges.

Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S.

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.

Read more Medical News

› Verified 9 days ago